↓ Skip to main content

What is the future of targeted therapy in rheumatology: biologics or small molecules?

Overview of attention for article published in BMC Medicine, March 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)

Mentioned by

twitter
5 tweeters
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
167 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
What is the future of targeted therapy in rheumatology: biologics or small molecules?
Published in
BMC Medicine, March 2014
DOI 10.1186/1741-7015-12-43
Pubmed ID
Authors

Attila Mócsai, László Kovács, Péter Gergely

Abstract

Until late in the 20th century, the therapy of rheumatic diseases relied on the use of drugs that had been developed through empirical approaches without detailed understanding of the molecular mechanisms involved. That approach changed with the introduction of biologic therapeutics at the end of the 20th century and by the recent development of small-molecule inhibitors of intracellular signal transduction pathways. Here we compare and discuss the advantages and disadvantages of those two groups of targeted anti-inflammatory therapeutics.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Argentina 1 <1%
Canada 1 <1%
Netherlands 1 <1%
Denmark 1 <1%
Japan 1 <1%
Germany 1 <1%
Unknown 159 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 34 20%
Researcher 27 16%
Student > Ph. D. Student 22 13%
Student > Bachelor 19 11%
Other 18 11%
Other 30 18%
Unknown 17 10%
Readers by discipline Count As %
Medicine and Dentistry 50 30%
Agricultural and Biological Sciences 22 13%
Pharmacology, Toxicology and Pharmaceutical Science 18 11%
Biochemistry, Genetics and Molecular Biology 15 9%
Chemistry 13 8%
Other 20 12%
Unknown 29 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2019.
All research outputs
#4,099,047
of 17,353,889 outputs
Outputs from BMC Medicine
#1,773
of 2,703 outputs
Outputs of similar age
#42,677
of 194,882 outputs
Outputs of similar age from BMC Medicine
#1
of 1 outputs
Altmetric has tracked 17,353,889 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,703 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,882 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them